Women (N = 535) | Ā | Ā | Ā |
---|---|---|---|
Ā | Odds ratio | P | 95% CI |
TZD therapy | 2.07 | 0.01 | 1.18ā3.63 |
Age | 1.02 | 0.25 | 0.99ā1.04 |
Biguanide use | 1.63 | 0.09 | 0.93ā2.84 |
Sulfonylurea use | 0.49 | 0.02 | 0.27ā0.89 |
Glycosolated hemoglobin A1C, % | 0.94 | 0.59 | 0.76ā1.17 |
Body mass index, kg/m2 | 0.97 | 0.07 | 0.93ā1.00 |
Cigarette smoking | 0.43 | 0.06 | 0.18ā1.03 |
High comorbidity conditions | 2.90 | 0.001 | 1.56ā5.41 |
Number of prescription medications | 1.09 | 0.03 | 1.01ā1.18 |
Men (N = 448) | Ā | Ā | Ā |
TZD therapy | 1.20 | 0.63 | 0.58ā2.46 |
Age | 1.05 | 0.01 | 1.01ā1.08 |
Biguanide use | 0.99 | 0.97 | 0.51ā1.91 |
Sulfonylurea use | 1.22 | 0.56 | 0.63ā2.35 |
Glycosolated hemoglobin A1C, % | 0.83 | 0.22 | 0.62ā1.12 |
Body mass index, kg/m2 | 0.97 | 0.32 | 0.91ā1.03 |
Cigarette smoking | 0.78 | 0.62 | 0.30ā2.03 |
High comorbidity conditions | 4.29 | <0.001 | 2.11ā8.72 |
Number of prescription medications | 0.89 | 0.018 | 0.80ā0.98 |